The many faces of α-synuclein: From structure and toxicity to therapeutic target

Hilal A. Lashuel, Cassia R. Overk, Abid Oueslati, Eliezer Masliah

Research output: Contribution to journalArticle

549 Citations (Scopus)

Abstract

Disorders characterized by α-synuclein (α-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which α-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of α-syn and their role in regulating α-syn function in health and disease. Understanding the nature of the various α-syn structures, how they are formed and their relative contributions to α-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.

Original languageEnglish
Pages (from-to)38-48
Number of pages11
JournalNature Reviews Neuroscience
Volume14
Issue number1
DOIs
Publication statusPublished - 1 Jan 2013
Externally publishedYes

Fingerprint

Synucleins
Lewy Body Disease
Dementia
Health
Therapeutics
Parkinson Disease, Familial, Type 1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The many faces of α-synuclein : From structure and toxicity to therapeutic target. / Lashuel, Hilal A.; Overk, Cassia R.; Oueslati, Abid; Masliah, Eliezer.

In: Nature Reviews Neuroscience, Vol. 14, No. 1, 01.01.2013, p. 38-48.

Research output: Contribution to journalArticle

Lashuel, Hilal A. ; Overk, Cassia R. ; Oueslati, Abid ; Masliah, Eliezer. / The many faces of α-synuclein : From structure and toxicity to therapeutic target. In: Nature Reviews Neuroscience. 2013 ; Vol. 14, No. 1. pp. 38-48.
@article{3e232a53139f4904b2d7b71fe9410907,
title = "The many faces of α-synuclein: From structure and toxicity to therapeutic target",
abstract = "Disorders characterized by α-synuclein (α-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which α-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of α-syn and their role in regulating α-syn function in health and disease. Understanding the nature of the various α-syn structures, how they are formed and their relative contributions to α-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.",
author = "Lashuel, {Hilal A.} and Overk, {Cassia R.} and Abid Oueslati and Eliezer Masliah",
year = "2013",
month = "1",
day = "1",
doi = "10.1038/nrn3406",
language = "English",
volume = "14",
pages = "38--48",
journal = "Nature Reviews Neuroscience",
issn = "1471-003X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The many faces of α-synuclein

T2 - From structure and toxicity to therapeutic target

AU - Lashuel, Hilal A.

AU - Overk, Cassia R.

AU - Oueslati, Abid

AU - Masliah, Eliezer

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Disorders characterized by α-synuclein (α-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which α-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of α-syn and their role in regulating α-syn function in health and disease. Understanding the nature of the various α-syn structures, how they are formed and their relative contributions to α-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.

AB - Disorders characterized by α-synuclein (α-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which α-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of α-syn and their role in regulating α-syn function in health and disease. Understanding the nature of the various α-syn structures, how they are formed and their relative contributions to α-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.

UR - http://www.scopus.com/inward/record.url?scp=84871414210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871414210&partnerID=8YFLogxK

U2 - 10.1038/nrn3406

DO - 10.1038/nrn3406

M3 - Article

C2 - 23254192

AN - SCOPUS:84871414210

VL - 14

SP - 38

EP - 48

JO - Nature Reviews Neuroscience

JF - Nature Reviews Neuroscience

SN - 1471-003X

IS - 1

ER -